drugset / Trial / NCT00483275
Fall Prevention by Alfacalcidol and Training
Phase 4
Withdrawn
484 enrolled
Ruhr University of Bochum
Teva Branded Pharmaceutical Products R&D, Inc. · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
Objective of the study is to evaluate the effect of a multimodal therapy on the basis of current guidelines on fall prevention consisting of a 12-months intervention with Alfacalcidol and calcium, patient education and a mobility program in a group of patients 65 years of age or older with an impaired renal function in comparison to a group receiving usual care.
Timeline
- Start
- 2007-06
- Primary completion
- —
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alfacalcidol | Other / unclassified | 1 ug | — |